A Phase 4 interventional study of IV iron in Anemia, Iron Deficiency, sponsored by Sutter Gould Medical Foundation. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-06-05.
Sponsored by Sutter Gould Medical Foundation · Phase 4, Interventional, and Treatment
Among 24 studies testing iron in Anemia, Iron-Deficiency — 3 open to participants now, 3 under way, none of them phase 3. Iron · Anemia, Iron-Deficiency.
Among the 24 studies testing iron in Anemia, Iron-Deficiency, this one is the 23rd largest by enrollment, is the only one that started in 2015, is one of 11 in phase 4, and was the 11th registered.
600 studies on the registry are indexed under Anemia, Iron-Deficiency; 95 are open to participants now.
Browse Anemia, Iron-Deficiency studies →3 of the 24 studies testing iron in Anemia, Iron-Deficiency are open now, in 2 countries. Each count lists the studies.
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 54 Anemia, Iron-Deficiency studies recruiting now, 19 (35%) set no upper age limit and 31 (57%) stop at 75 or younger; 15 take children under 18; 17 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →24 studies; the count open now beside each. This study's row is marked.
First in 1997; this study’s year is marked. 1 started in 2015.
Median enrollment 107 across the 24 interventional studies. Of the 12 that completed or were terminated, 1 (8%) have results posted.
2 of 24 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Sutter Gould Medical Foundation as lead sponsor.
Sutter Gould Medical Foundation has 1 study filed under Anemia, Iron-Deficiency — fewer than ten, so there is no comparison to draw.
1 of the studies testing iron in Anemia, Iron-Deficiency that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06550362Loma Linda UniversityDaily Iron vs Every-other-day Iron for Pediatric Patients With IDA | 2027-05 |
Among the 24 studies testing iron in Anemia, Iron-Deficiency, from their registry updates:
The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia.
The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia. The two dosing regimens under review are a low dose weekly or a larger dose given every three weeks.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Hemoglobin (Hb)
The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
weekly dose of 100mg
Drug: IV iron
every 3 week dosage.
Drug: IV iron
IV iron infusion based on weekly or every 3 week dosage.
superior dosing regimen exists for INfed
shown by a 2gm/dl increase in HgB
Time frame: 3 years
High Dose Effect
INfed can be given at high dose without an increase in AE and/or SAEs frequency
Time frame: 3 years
Plan to share: No
No publications or documents are linked to this record.
Ran from Apr 2015 to primary completion in Aug 2018, 40 months.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Iron